CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A Phase 1/2a, open-label, multicenter study of intramuscular (i.m.) PRL-02 depot in participants with advanced prostate cancer....
Phase 1, Phase 2
Miamisburg, Ohio, United States and 13 other locations
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Kettering, Ohio, United States and 92 other locations
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Cincinnati, Ohio, United States and 107 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Cincinnati, Ohio, United States of America and 44 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...
Phase 3
Cincinnati, Ohio, United States and 72 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Cincinnati, Ohio, United States of America and 28 other locations
of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...
Cincinnati, Ohio, United States of America and 29 other locations
The purpose of this study is to determine the proportion of men with residual/recurrent clinically significant prostate cancer (Gra...
Phase 2
Cincinnati, Ohio, United States
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Cincinnati, Ohio, United States and 220 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Cincinnati, Ohio, United States and 388 other locations
Clinical trials
Research sites
Resources
Legal